Global Epidemiology (Jun 2024)

Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru

  • Charles Huamaní,
  • Fátima Concha-Velasco,
  • Lucio Velásquez,
  • María K. Antich,
  • Johar Cassa,
  • Kevin Palacios,
  • Luz Bernable-Villasante,
  • Guido Giraldo-Alencastre,
  • Eduarda Benites-Calderon,
  • Sebastian Mendieta-Nuñez,
  • Heber Quispe-Jihuallanca,
  • Matilde Quispe-Yana,
  • Karla Zavala-Vargas,
  • Liesbeth Hinojosa-Florez,
  • Javier Ramírez-Escobar,
  • Juan Spelucin-Runciman,
  • Antonio Bernabe-Ortiz

Journal volume & issue
Vol. 7
p. 100131

Abstract

Read online

Background: The spread of the coronavirus disease 2019 (COVID-19) in Peru has been reported at the regional level, few studies have evaluated its spread at the provincial level, in which the mechanisms could be different. Methods: We conducted an analytical, cross-sectional, multistage observational population study to assess the seroprevalence of SARS-COV-2 at the provincial and urban/rural levels in a high-altitude setting. The sampling unit was the household, including a randomly selected family member. Sampling was performed using a data collection sheet on clinical and epidemiological variables. Chemiluminescence tests were used to detect total anti-SARS-COV-2 antibodies (IgG and IgM simultaneously). The percentages were adjusted to the sampling design. Results: The overall prevalence in the region of Cusco was 25.9%, with considerably different prevalence between the 13 provinces (from 15.9% in Acomayo to 40.1% in Canchis) and between rural (21.1%) and urban (31.7%) areas. In multivariable model, living in a rural area was a protective factor (adjusted prevalence ratio [aPR], 0.68; 95% confidence interval [CI], 0.61–0.76). Conclusions: Geographic diversity and population density determine different prevalence rates, typically lower in rural areas, possibly due to natural social distancing or limited interaction with people at risk.

Keywords